TEZ BIO Trademark

Trademark Overview


On Wednesday, July 30, 2025, a trademark application was filed for TEZ BIO with the United States Patent and Trademark Office. The USPTO has given the TEZ BIO trademark a serial number of 99311084. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 10, 2026. This trademark is owned by POPVAX PRIVATE LIMITED. The TEZ BIO trademark is filed in the Insurance & Financial Services and Computer & Software Services & Scientific Services categories with the following description:

Biological research; medical research; scientific laboratory services; scientific research; chemical research; research and development of new products for others; technological research in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; scientific, medical, biological research and development in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; conducting clinical trials for others and testing services in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; engineering services relating to research and development of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nu...

Providing private equity and investment funding; venture capital services, namely, providing financing to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing working capital financing to businesses and business owners, namely, emerging and start-up companies; providing working capital financing to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices com...
tez bio

General Information


Serial Number99311084
Word MarkTEZ BIO
Filing DateWednesday, July 30, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2026

Trademark Statements


NOT AVAILABLE"BIO"
Goods and ServicesBiological research; medical research; scientific laboratory services; scientific research; chemical research; research and development of new products for others; technological research in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; scientific, medical, biological research and development in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; conducting clinical trials for others and testing services in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; engineering services relating to research and development of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers and formulations for use in manufacturing of pharmaceutical, vaccines, medicines, biologics, biotherapeutics, and biosimilars; creation of websites for others featuring information in the pharmaceutical, medical and health fields; hosting of a website featuring information in the pharmaceutical, medical and health fields; hosting podcasts in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; software as a service (saas) services featuring computer software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, and analytical characterization for production or manufacturing of pharmaceutical and biopharmaceutical preparations, data management, or clinical trial management
Goods and ServicesProviding private equity and investment funding; venture capital services, namely, providing financing to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing working capital financing to businesses and business owners, namely, emerging and start-up companies; providing working capital financing to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing venture capital, development capital, private equity and investment funding to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; providing venture capital, development capital, private equity and investment funding to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing funding for joint ventures in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing funding for inventions in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing funding for research, development, and commercialization of products and services in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing project grants for research, development, and commercialization of products and services in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; equity capital investment; loan financing of business ventures; creation and management of venture capital investment funds that invest in emerging companies, start-up companies, small businesses, developing companies, and late-stage companies, and entrepreneurs; creation and management of venture capital investment funds that invest in pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, July 30, 2025
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 30, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePOPVAX PRIVATE LIMITED
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressMUMBAI CITY, MAHARASHTRA 400049
IN

Party NamePOPVAX PRIVATE LIMITED
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressMUMBAI CITY, MAHARASHTRA 400049
IN

Trademark Events


Event DateEvent Description
Wednesday, July 30, 2025NEW APPLICATION ENTERED
Wednesday, July 30, 2025APPLICATION FILING RECEIPT MAILED
Monday, December 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 15, 2025ASSIGNED TO EXAMINER
Monday, December 15, 2025NON-FINAL ACTION WRITTEN
Monday, December 15, 2025NON-FINAL ACTION E-MAILED
Monday, December 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 13, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 13, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 13, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 17, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 4, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 10, 2026PUBLISHED FOR OPPOSITION
Tuesday, March 10, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED